Epidemiological considerations in planning HIV preventive vaccine trials.
Esparza
J
J
WHO-UNAIDS HIV Vaccine Initiative, Health Technology and Pharmaceuticals, World Health Organization, 1211 Geneva 27, Switzerland. esparzaj@who.ch
Burke
D
D
D016915:AIDS Vaccines / Q000008:administration & dosage; D002986:Clinical Trials as Topic / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000453:epidemiology* / Q000517:prevention & control*; D006801:Humans; D008297:Male; D012107:Research Design
D016915:AIDS Vaccines